Free Trial
→ The Iran War Isn’t Chaos. It’s Strategy. (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$0.71
-3.1%		$0.94
$0.69
▼
$2.38
$320.35M0.782.65 million shs2.40 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+0.3%		$3.27
$2.28
▼
$3.61
$1.18B0.9870,511 shs865,718 shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
▼
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$3.04
-5.3%		$4.15
$3.03
▼
$16.20
$449.28M1.914.31 million shs3.02 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.00%-13.80%-24.08%-24.14%-51.16%
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00%-0.62%-4.75%+15.05%+24.42%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.00%-14.12%-22.84%-29.30%-81.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$0.71
-3.1%		$0.94
$0.69
▼
$2.38
$320.35M0.782.65 million shs2.40 million shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$3.21
+0.3%		$3.27
$2.28
▼
$3.61
$1.18B0.9870,511 shs865,718 shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
▼
$115.00
$6.88B0.38180 shsN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$3.04
-5.3%		$4.15
$3.03
▼
$16.20
$449.28M1.914.31 million shs3.02 million shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.00%-13.80%-24.08%-24.14%-51.16%
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00%-0.62%-4.75%+15.05%+24.42%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.00%-14.12%-22.84%-29.30%-81.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Canopy Growth Corporation stock logo
CGC
Canopy Growth
2.20
HoldN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
2.60
Moderate Buy$2.30-28.35% Downside
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00
N/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.38
Hold$5.9094.08% Upside

Current Analyst Ratings Breakdown

Latest CGC, STDAF, TLRY, and CRON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/16/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
10/9/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$4.50 ➝ $4.00
10/8/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeBuy (B-) ➝ Buy (B)
10/8/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
10/5/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
TD logo
TD
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$4.70 ➝ $4.50
10/2/2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
9/29/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold ➝ Strong Sell
9/28/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
TD Securities logo
TD Securities
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
9/22/2026
Cronos Group Inc. stock logo
CRON
Cronos Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C+) ➝ Buy (B-)
9/21/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
9/21/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
ATB Cormark Capital Markets logo
ATB Cormark Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetHold$8.00 ➝ $6.00
(Data available from 10/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$293.63M1.09N/AN/A$1.13 per share0.63
Cronos Group Inc. stock logo
CRON
Cronos Group
$179.09M6.61$0.01 per share256.04$3.00 per share1.07
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$3.84B1.79$11.12 per share9.93$23.11 per share4.78
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$210.48M2.13N/AN/A$10.87 per share0.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$190.29M-$0.45N/AN/AN/A-65.33%-21.91%-14.34%11/6/2026 (Estimated)
Cronos Group Inc. stock logo
CRON
Cronos Group
-$9.45M$0.2016.05N/AN/A39.08%4.85%4.62%11/5/2026 (Estimated)
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$292.15MN/AN/AN/AN/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$121.40M-$1.40N/AN/AN/A-16.91%-10.39%-7.38%N/A

Latest CGC, STDAF, TLRY, and CRON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2026Q2 2027
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.03N/AN/AN/A$57.72 millionN/A
11/5/2026Q3 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.03N/AN/AN/A$51.15 millionN/A
10/8/2026Q1 2027
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.1814-$0.02+$0.1614-$0.32$266.26 million$257.15 million
8/7/2026Q1 2027
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.04-$0.02+$0.02-$0.02$58.21 million$142.62 million
8/6/2026Q2 2026
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.09+$0.08$0.09$44.20 million$53.01 million
7/28/2026Q4 2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.0120-$0.43-$0.4180-$0.43$246.30 million$281.71 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Canopy Growth Corporation stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.31
3.04
2.39
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
16.18
15.25
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
2.23
1.54
0.99
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.17
1.88
1.11

Institutional Ownership

CompanyInstitutional Ownership
Canopy Growth Corporation stock logo
CGC
Canopy Growth
3.33%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.35%
Cronos Group Inc. stock logo
CRON
Cronos Group
7.80%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
1.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Canopy Growth Corporation stock logo
CGC
Canopy Growth
1,128449.30 million447.73 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
610368.54 million339.80 millionOptionable
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
12,50062.34 millionN/ANot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
3,595147.79 million145.42 millionOptionable

Recent News About These Companies

Tilray Brands (TSX:TLRY): Why Is It Moving Up Cannabis Stocks Watchlists?
October 17 at 10:26 PM  |  kalkinemedia.comK
Promising Cannabis Stocks To Watch Now - October 14th
October 17 at 4:05 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31128718
Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.3% - Time to Sell?
October 16 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tilray-brands-nasdaq-tlry-stock-price-down-53-time-to-sell-2026-10-16/
Best Cannabis Stocks To Consider - October 16th
October 16 at 12:02 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-best-cannabis-stocks-to-consider-october-16th-2026-10-16/
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
October 15 at 5:54 PM  |  fool.comhttps://www.fool.com/coverage/better-buy/2026/10/15/canopy-growth-vs-tilray-brands-which-cannabis-stock-is-a-better-buy-in-2026/
Tilray Brands (NASDAQ:TLRY) Shares Up 2.2% - What's Next?
October 15 at 5:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tilray-brands-nasdaq-tlry-shares-up-22-whats-next-2026-10-15/
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
October 15 at 11:44 AM  |  finance.yahoo.comhttps://finance.yahoo.com/media-advertising/articles/sweetwater-brewing-gives-fans-chance-110000009.html
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
October 15 at 7:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/15/3381474/0/en/sweetwater-brewing-gives-fans-the-chance-to-win-tickets-to-their-dream-show-at-aeg-venues-across-georgia.html
Tilray Brands (NASDAQ:TLRY) Stock Price Down 4% - Here's Why
October 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tilray-brands-nasdaq-tlry-stock-price-down-4-heres-why-2026-10-14/
Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.1% Following Analyst Downgrade
October 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31117120
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.7% - Should You Sell?
October 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tilray-brands-nasdaq-tlry-stock-price-down-27-should-you-sell-2026-10-13/
Tilray Medical Gains Approval For In-House Quality Testing At Portugal Facility
October 13, 2026  |  rttnews.comhttps://www.rttnews.com/3698521/tilray-medical-gains-approval-for-in-house-quality-testing-at-portugal-facility.aspx
Tilray Medical's Portugal Lab Granted Approval for In-House Testing
October 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tilray-medical-apos-portugal-lab-112438275.html
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated ...
October 13, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/GlobeNewswire/36977806/tilray-medical-strengthens-global-medical-cannabis-supply-chain-with-approval-to-bring-critical-eu-gmp-quality-testing-in-house-accelerating-product-release-across-regulated-global-markets/
Cannabis Stocks To Research - October 13th
October 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-cannabis-stocks-to-research-october-13th-2026-10-13/
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
October 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/tilray-medical-strengthens-global-medical-110000461.html
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
October 13, 2026  |  financialpost.comF
BrewDog Acquisition Boosts Tilray's Q1 Performance
October 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4953640-brewdog-acquisition-boosts-tilrays-stock-q1-performance
Is Tilray Brands (NASDAQ:TLRY) Ready for Its Next Market Test?
October 12, 2026  |  kalkinemedia.comK
3 Huge Red Flags From Tilray's Q1 Earnings Report
October 12, 2026  |  fool.comhttps://www.fool.com/investing/2026/10/12/3-huge-red-flags-from-tilray-s-q1-earnings-report/
Tilray Q1: Not Looking Good, Remains A 'Hold'
October 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4953597-tilray-q1-not-looking-good-remains-a-hold

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Illuminated Nike swoosh logo on a wall above a display pedestal with sneakers in a retail store.
Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
By Thomas Hughes | October 4, 2026
Bloom Energy fuel cell units installed outside a data center building labeled "AI" at dusk.
Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
By Thomas Hughes | September 21, 2026
Rows of flowering cannabis plants grow under industrial grow lights inside a commercial indoor cultivation facility.
Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
By Jeffrey Neal Johnson | October 6, 2026
Tilray logo overlaid on a cannabis cultivation and processing facility with plants and packaged product jars.
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
By Jeffrey Neal Johnson | October 9, 2026
Canopy Growth stock logo

Canopy Growth NASDAQ:CGC

$0.71 -0.02 (-3.06%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$0.72 +0.01 (+1.12%)
As of 10/16/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$3.21 +0.01 (+0.31%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$3.24 +0.02 (+0.78%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft stock logo

STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF

$110.42 0.00 (0.00%)
As of 10/24/2022

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$3.04 -0.17 (-5.30%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$3.04 0.00 (-0.13%)
As of 10/16/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas